Fibrotic disease and the TH1/TH2 paradigm
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Normally, myofibroblasts carefully coordinate the breakdown of granulation tissue and replacement with long-lasting type I collagen [100].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“However, it is now described as a general immunosuppressive cytokine that downregulates chronic inflammatory responses through many mechanism”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Cited by
Items 601–700 of 1,000
Gao, W., Jian-Xin, L. I. U., Liu, M., Yao, Y.-D., Liu, Z., Liu, L., He, H., & Zhou, H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105563 · Cited by 49
Cellular and Molecular Mechanisms of Intestinal Fibrosis
Wu, X., Lin, X., Tan, J., Liu, Z., He, J., Hu, F., Wang, Y., Chen, M., Liu, F., & Mao, R. (2023) · Gut and Liver · doi:10.5009/gnl220045 · Cited by 57
Ng, M., Borst, R., Gacaferi, H., Davidson, S., Ackerman, J. E., Johnson, P. A., Machado, C. C., Reekie, I. R., Attar, M., Windell, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45341-9 · Cited by 54
King, P. T., Lim, S. C. L., Pick, A., Ngui, J., Prodanovic, Z., Downey, W., Choong, C. K. C., Kelman, A., Baranyai, E., Francis, M. J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.09.030 · Cited by 46
Trypsin, Tryptase, and Thrombin Polarize Macrophages towards a Pro-Fibrotic M2a Phenotype
White, M. J. V., & Gomer, R. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138748 · Cited by 52
IL-33-ST2 Axis in Liver Disease: Progression and Challenge
Sun, Z., Chang, B., Gao, M., Zhang, J., & Zou, Z. (2017) · Mediators of Inflammation · doi:10.1155/2017/5314213 · Cited by 52
“In contrast, Th2 cytokines, such as IL-13, promote hepatic stellate cell (HSC) proliferation, transforming growth factor-β (TGF-β) synthesis, and fibrogenesis [59].”
BackgroundEngineering an immunomodulatory drug-eluting stent to treat laryngotracheal stenosis
Duvvuri, M., Motz, K., Murphy, M. K., Feeley, M., Ding, D., Lee, A. H., Elisseeff, J. H., & Hillel, A. T. (2019) · Biomaterials Science · doi:10.1039/c8bm01623b · Cited by 46
IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis
Birnhuber, A., Crnković, S., Biasin, V., Marsh, L. M., Odler, B., Sahu-Osen, A., Stacher‐Priehse, E., Brčić, L., Schneider, F., Čikeš, N., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00154-2019 · Cited by 47
Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases
Solaymani-Mohammadi, S., Eckmann, L., & Singer, S. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00401 · Cited by 48
“…TH2 polarization, mainly in response to Schistosoma egg antigens, promotes liver fibrosis during human schistosomiasis, whereas a TH1-biased immune response inhibits the development of liver fibrosis during schistosomiasis (Mentink-Kane and Wynn, 2004; Wynn, 2004; Wynn et al., 2004).”
BackgroundLiu, H., Wu, M., Jia, Y., Niu, L., Huang, G., & Xu, F. (2020) · NPG Asia Materials · doi:10.1038/s41427-020-0226-7 · Cited by 48
Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis
Belmesk, L., Muntyanu, A., Cantin, E., Alhalees, Z., Jack, C. S., Le, M., Sasseville, D., Iannattone, L., Ben‐Shoshan, M., Litvinov, I. V., et al. (2021) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754211027858 · Cited by 52
Understanding Scarring in the Oral Mucosa
Griffin, M., Fahy, E. J., King, M. E., Guardino, N. J., Chen, K., Abbas, D. B., Lavin, C. V., Deleon, N. M. D., Lorenz, H. P., Longaker, M. T., et al. (2021) · Advances in Wound Care · doi:10.1089/wound.2021.0038 · Cited by 50
Group Young Researchers in Inflammatory Carcinogenesis, Wandmacher, A. M., Mehdorn, A., & Sebens, S. (2021) · Cancers · doi:10.3390/cancers13194932 · Cited by 58
Fibroblasts—Warriors at the Intersection of Wound Healing and Disrepair
Roman, J. (2023) · Biomolecules · doi:10.3390/biom13060945 · Cited by 55
Th2-Biased Immune Responses Are Important in a Murine Model of Chronic Hypersensitivity Pneumonitis
Mitaka, K., Miyazaki, Y., Yasui, M., Furuie, M., Miyake, S., Inase, N., & Yoshizawa, Y. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000321114 · Cited by 55
The Role of the Immune Response in the Pathogenesis of Bronchiectasis
King, P. T. (2018) · BioMed Research International · doi:10.1155/2018/6802637 · Cited by 52
“A Th1 immune response is generallymore inflammatory than aTh2 response andWynn has proposed that in chronic inflammatory disease the downregulation of Th1 immunity may potentially reduce host damage [102].”
BackgroundIL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts
Xu, X., Luo, S., Li, B., Dai, H., & Zhang, J. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219843827 · Cited by 47
The role of the acquired immune response in systemic sclerosis
Chizzolini, C., & Boin, F. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0509-1 · Cited by 52
Toll-like Receptors, Notch Ligands, and Cytokines Drive the Chronicity of Lung Inflammation
Raymond, T., Schaller, M. A., Hogaboam, C. M., Lukacs, N. W., Rochford, R. A., & Kunkel, S. L. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200706-067th · Cited by 49
“Regarding the immune response, an increase in type 2 cytokines provides the mechanism for the expression of additional subclasses of antibody (IgE), the participation of an additional subpopulation of leukocytes (eosinophils), and the involvement of alternately activated (reparative) macrophages (21, 22).”
Maintenance of radiation-induced intestinal fibrosis: Cellular and molecular features
Haydont, V., & Vozenin-Brotons, M.-C. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i19.2675 · Cited by 47
Fibrosis and bone marrow: understanding causation and pathobiology
Ghosh, K., Shome, D. K., Kulkarni, B. P., Ghosh, K. K., & Ghosh, K. K. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04393-z · Cited by 56
Sakaguchi, S., Shono, J., Suzuki, T., Sawano, S., Anderson, J. E., Do, M. Q., Ohtsubo, H., Mizunoya, W., Sato, Y., Nakamura, M., et al. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.032 · Cited by 52
AMPK regulates macrophage polarization in adipose tissue inflammation and NASH
Weng, S., & Schuppan, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.031 · Cited by 45
Lin, F., Taylor, N. J., Su, H., Huang, X., Hussain, M. J., Abeles, R. D., Blackmore, L., Zhou, Y., Ikbal, M. M., Heaton, N. D., et al. (2013) · Hepatology · doi:10.1002/hep.26334 · Cited by 44
Role of Bone Marrow-Derived Fibroblasts in Renal Fibrosis
Yan, J., Zhang, Z., Jia, L., & Wang, Y. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00061 · Cited by 48
“Naïve CD4+ T cells can differentiate into two major distinct phenotypes, Th1 and Th2 cells, which are characterized by specific cytokine expression patterns (Wynn, 2004).”
BackgroundMechanisms Underlying Adenomyosis-Related Fibrogenesis
Kobayashi, H., Kishi, Y., & Matsubara, S. (2019) · Gynecologic and Obstetric Investigation · doi:10.1159/000502822 · Cited by 51
Roderfeld, M., Räth, T., Pasupuleti, S., Zimmermann, M., Neumann, C., Churin, Y., Dierkes, C., Voswinckel, R., Barth, P. J., Zahner, D., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300608 · Cited by 48
Gangadharan, B., Hoeve, M. A., Allen, J. E., Ebrahimi, B., Rhind, S. M., Dutia, B. M., & Nash, A. A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507270 · Cited by 44
Therapeutic targeting of the IL-13 pathway in skin inflammation
Tubau, C., & Puig, L. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1858802 · Cited by 50
“IL-13, because of the predominance of its receptors in peripheral tissues, seems to be the dominant effector cytokine of fibrosis [106].”
BackgroundA comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases
Balaya, R. D. A., Vaid, N., Deepak, K., Dagamajalu, S., & Prasad, T. S. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07539-2 · Cited by 47
Yi, C., Liu, J., Deng, W., Luo, C., Qi, J., Chen, M., & Xu, H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02731-y · Cited by 48
“, lung, kidney, liver and heart) is the leading cause of morbidity and mortality accounting for ~ 45% of all causes of death in the United States [1].”
BackgroundThe roles of Th cells in myocardial infarction
Liu, J., Liu, F., Liang, T., Zhou, Y., Su, X., Li, X., Zeng, J., Qu, P., Wang, Y., Chen, F., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02064-6 · Cited by 50
Linking Inflammation Reactions to Cancer: Novel Targets for Therapeutic Strategies
Mantovani, A., Marchesi, F., Porta, C., Allavena, P., & Sica, A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73898-7_9 · Cited by 48
Interleukin Expression after Injury and the Effects of Interleukin-1 Receptor Antagonist
Chamberlain, C. S., Leiferman, E. M., Frisch, K. E., Brickson, S. L., Murphy, W. L., Baer, G. S., & Vanderby, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071631 · Cited by 49
Th2-like immune response in radiation-induced lung fibrosis
Xie, C. (2011) · Oncology Reports · doi:10.3892/or.2011.1300 · Cited by 43
“They also play a central role in the pathogenesis of a variety of fibrotic disorders, including progressive systemic sclerosis, idiopathic pulmonary fibrosis, bleomycin lung and hepatic fibrosis (6-8).”
Cox, N., Pilling, D., & Gomer, R. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400281 · Cited by 42
Dong, J., & Ma, Q. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1711-1 · Cited by 45
“However, an overzealous or persistent Th2 response would result in progressive and lethal fibrosis (Wynn 2004).”
BackgroundAdegunsoye, A., Hrusch, C. L., Bonham, C. A., Jaffrey, M. R., Blaine, K. M., Sullivan, M., Churpek, M. M., Strek, M. E., Noth, I., & Sperling, A. I. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00516 · Cited by 48
Tubulin beta 3 and 4 are involved in the generation of early fibrotic stages
Wawro, M. E., Sobierajska, K., Ciszewski, W. M., Wagner, W., Frontczak, M., Wieczorek, K., & Niewiarowska, J. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.06.014 · Cited by 44
Current perspectives on the role of CD8+ T cells in systemic sclerosis
Fuschiotti, P. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.10.002 · Cited by 47
T‐Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis
Hillel, A. T., Ding, D., Samad, I., Murphy, M. K., & Motz, K. (2018) · The Laryngoscope · doi:10.1002/lary.27321 · Cited by 46
Russo, R. L., Cozzani, E., Gasparini, G., & Parodi, A. (2019) · Dermatologic Therapy · doi:10.1111/dth.13190 · Cited by 42
“…Parodi, 2019; Huaux, Liu, McGarry, Ullenbruch, & Phan, 2003; Kanellakis, Ditiatkovski, Kostolias, & Bobik, 2012; O'Reilly, 2013; Oh et al., 2011; Saito, Okazaki, Sugawara, & Yamamoto, 2003; Shimamura et al., 2008; Sugimoto, Enjoji, Nakamuta, & Ohta, 2005; Wynes, Franke, & Riches, 2004; Wynn, 2004).”
Takei, H., Yasuoka, H., Yoshimoto, K., & Takeuchi, T. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2112-7 · Cited by 49
Immunologic and imaging signatures in post tuberculosis lung disease
Singh, S., Allwood, B., Chiyaka, T., Kleyhans, L., Naidoo, C., Moodley, S., Theron, G., & Segal, L. N. (2022) · Tuberculosis · doi:10.1016/j.tube.2022.102244 · Cited by 64
Zheng, M., Liu, Z., & He, Y. (2024) · Immunology · doi:10.1111/imm.13788 · Cited by 50
“Th2 cells accelerate ECM deposition and are thought to be pro-fibrotic, while Th1 cell cytokines exert a protective role from fibrosis [71, 72].”
BackgroundImmunoregulation byTaenia crassicepsand Its Antigens
Peón, A. N., Espinoza-Jiménez, A., & Terrazas, L. I. (2012) · BioMed Research International · doi:10.1155/2013/498583 · Cited by 44
Jang, H., Kim, J. I., Jung, K.-J., Kim, J., Han, K., & Park, K. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.016 · Cited by 42
“A number of studies have demonstrated that infiltration of BMDCs into injured sites triggers initiation of pathogenesis, promotes a pathological situation, and sustains chronic dysfunction of organs [1,6,8,18,41].”
BackgroundA microglial hypothesis of globoid cell leukodystrophy pathology
Nicaise, A. M., Bongarzone, E. R., & Crocker, S. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23773 · Cited by 46
“In addition, these cells support tissue remodeling and promote fibrosis through Arg-1 activity, which can also be used as a marker for this microglial phenotype (Hesse et al., 2001; Wynn, 2004).”
BackgroundPeriostin in the pathogenesis of skin diseases
Murota, H., Lingli, Y., & Katayama, I. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2647-1 · Cited by 45
Qu, H., Liu, L., Liu, Z., Qin, H., Liao, Z., Xia, P., Yang, Y., Li, B., Gao, F., & Cai, J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0240-4 · Cited by 48
Epitranscriptomic 5-Methylcytosine Profile in PM2.5-Induced Mouse Pulmonary Fibrosis
Han, X., Liu, H., Zhang, Z., Yang, W., Wu, C., Liu, X., Zhang, F., Sun, B., Zhao, Y., Jiang, G., et al. (2020) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.11.005 · Cited by 52
Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension
Liang, S., Desai, A. A., Black, S. M., & Tang, H. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63046-1_15 · Cited by 50
Pulmonary Hypertension Can Be a Sequela of Prior Pneumocystis Pneumonia
Swain, S. D., Han, S. J., Harmsen, A. L., Shampeny, K., & Harmsen, A. G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070178 · Cited by 43
Li, A. G., Quinn, M. J., Siddiqui, Y., Wood, M. D., Federiuk, I. F., Duman, H. M., & Ward, W. K. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31168 · Cited by 42
Central Nervous System Fibrosis Is Associated with Fibrocyte-Like Infiltrates
Aldrich, A. L., & Kielian, T. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.036 · Cited by 44
Guo, H., Yu, R., Zhang, H., & Wang, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111263 · Cited by 47
Ntsekhe, M., Wiysonge, C. S., Gumedze, F. N., Maartens, G., Commerford, P., Volmink, J. A., & Mayosi, B. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002253 · Cited by 41
“This question is relevant because IL-13-secreting CD4 TH2 cells, which are reduced by HIV, regulate fibrogenesis directly, through stimulating collagen synthesis by fibroblasts and indirectly by promoting TGF-b1 production by macrophages [6].”
BackgroundGurrieri, C., Piazza, F., Gnoato, M., Montini, B., Biasutto, L., Gattazzo, C., Brunetta, E., Cabrelle, A., Cinetto, F., Niero, R., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.153049 · Cited by 48
“Alternatively, the role of chronic inflammatory response in IPF pathogenesis has represented a subject of intense research for many years (Shen et al., 1988; Green, 2002; Wynn, 2004).”
BackgroundRole of mast cells in fibrosis of classical Hodgkin lymphoma
Nakayama, S., Yokote, T., Hiraoka, N., Nishiwaki, U., Hanafusa, T., Nishimura, Y., & Tsuji, M. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016644447 · Cited by 42
Mathematical modeling of liver fibrosis
Friedman, A., & Hao, W. (2016) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2017010 · Cited by 47
Radiation-induced muscle fibrosis rat model: establishment and valuation
Zhou, Y., Sheng, X., Deng, F., Wang, H., Shen, L., Zeng, Y., Ni, Q., Zhan, S., & Zhou, X. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1104-0 · Cited by 45
Damba, T., Zhang, M., Buist‐Homan, M., van Goor, H., Faber, K. N., & Moshage, H. J. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.08.004 · Cited by 45
“Therefore, it is important to understand the mechanisms that lead to hepatic stellate cell activation and hepatic fibrosis [3,4].”
BackgroundBigaeva, E., Gore, E., Simon, E., Zwick, M., Oldenburger, A., de Jong, K. P., Hofker, H. S., Schlepütz, M., Nicklin, P. L., Boersema, M., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02611-6 · Cited by 44
“Cytokine release profiles of human healthy and diseased PCTS As part of cellular mechanisms of fibrosis, damaged epithelial cells and (resident) immune cells secrete various cytokines that drive the inflammatory and fibrogenic responses (Wynn 2004).”
BackgroundKielian, T., Syed, M., Liu, S., Phulwani, N. K., Phillips, N., Wagoner, G., Drew, P. D., & Esen, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5004 · Cited by 44
“Another distinction between the regulated fibrosis that occurs during brain abscess development and pathological fibrosis is that the latter is typically associated with a Th2 cytokine environment (59, 60), which is not the case during brain abscess development where a Th1 response predominates (T.”
BackgroundShi, J., Li, Q., Sheng, M., Zheng, M., Yu, M., & Zhang, L. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453204 · Cited by 42
Nauffal, V., Klarqvist, M. D. R., Hill, M. C., Pace, D. F., Achille, P. D., Choi, S. H., Rämö, J. T., Pirruccello, J. P., Singh, P., Kany, S., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03010-w · Cited by 44
Histological signatures map anti-fibrotic factors in mouse and human lungs
Guo, J. L., Griffin, M., Yoon, J.-K., Lopez, D. M., Zhu, Y., Lu, J. M., Mikos, G., Parker, J. B. L., Mascharak, S., Brenac, C., et al. (2025) · Nature · doi:10.1038/s41586-025-08727-3 · Cited by 54
Embryonic stem cell–derived M2‐like macrophages delay cutaneous wound healing
Dreymueller, D., Denecke, B., Ludwig, A., & Jahnen‐Dechent, W. (2013) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00858.x · Cited by 40
Liao, W., Bao, Z., Chang, C. K., Mok, Y., & Wong, W. S. F. (2008) · PROTEOMICS · doi:10.1002/pmic.200700954 · Cited by 50
Shen, J., Chelvam, V., Cresswell, G. M., & Low, P. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3006962 · Cited by 40
The inhibitory effect of ginsan on TGF‐β mediated fibrotic process
Ahn, J., Kim, M., Lim, M., Park, S., Lee, S., Yun, Y., & Song, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22452 · Cited by 40
“2010 Wiley-Liss, Inc. Fibrotic diseases, characterized by consistent and excessive wound healing responses, are a leading cause of morbidity and mortality (Wynn, 2004).”
BackgroundJun, Y. K., Kwon, S. H., Yoon, H. T., Park, H., Soh, H., Lee, H. J., Im, J. P., Kim, J. S., Kim, J. W., & Koh, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-76880-y · Cited by 42
Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis
Kunovský, L., Dítě, P., Jabandžiev, P., Dolina, J., Vaculová, J., Blaho, M., Bojková, M., Dvořáčková, J., Uvírová, M., Kala, Z., et al. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i8.835 · Cited by 44
Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis
Hasan, M., Paul, N. C., Paul, S. K., Saikat, A. S. M., Akter, H., Mandal, M., & Lee, S. (2022) · Molecules · doi:10.3390/molecules27051481 · Cited by 46
“Moreover, IL-13 has been commonly attributed to several systemic inflammatory disorders and to fibrosis progression [47].”
BackgroundBeretta, L., Cappiello, F., Moore, J. H., Barili, M., Greene, C. S., & Scorza, R. (2008) · Arthritis Care & Research · doi:10.1002/art.23836 · Cited by 40
The role of B cells in systemic sclerosis
van Laar, J. M., & Kraay (2008) · Biologics · doi:10.2147/btt.s2806 · Cited by 40
“The CD4+ T helper cells 2 (Th2) cytokines IL-4, IL-6, and IL-13 stimulate the synthesis of collagen by fi broblasts, leading to excessive scar formation and fi brosis (Duncan and Berman 1991; Wynn 2004).”
BackgroundHuman Microvascular Pericyte Basement Membrane Remodeling Regulates Neutrophil Recruitment
Sava, P., Cook, I. O., Mahal, R. S., & Gonzalez, A. L. (2014) · Microcirculation · doi:10.1111/micc.12173 · Cited by 45
Luo, L., He, Y., Chang, Q., Xie, G., Zhan, W., Wang, X., Zhou, T., Xing, M., & Lu, F. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s114295 · Cited by 41
Penke, L. R. K., Speth, J. M., Huang, S. K., Fortier, S. M., Baas, J. D., & Peters-Golden, M. L. (2022) · JCI Insight · doi:10.1172/jci.insight.160688 · Cited by 44
Ku, J. C., Raiten, J., & Li, Y. (2024) · Biomedical Engineering Advances · doi:10.1016/j.bea.2024.100118 · Cited by 49
Complex regulation of cardiac fibrosis: insights from immune cells and signaling pathways
Rao, W., Li, D., Zhang, Q., Liu, T., Gu, Z., Huang, L., Dai, J., Wang, J., & Hou, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06260-5 · Cited by 45
Pugliese, E., Coentro, J. Q., Raghunath, M., & Zeugolis, D. I. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.05.010 · Cited by 39
Chang, C., Lin, C., Lee, C., Chuang, H., Shih, F.-C., Wan, S.-W., Tai, C., & Chen, C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114356 · Cited by 46
Targeting SHP2 as a therapeutic strategy for inflammatory diseases
Liu, Y., Yang, X., Wang, Y., Yang, Y., Sun, D., Li, H., & Chen, L. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113264 · Cited by 41
Lim, W. T. H., Ooi, E. H., Foo, J. J., Ng, K. H., Wong, J. H. D., & Leong, S. S. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.03.030 · Cited by 41
Denis, O., van den Brûle, S., Heymans, J., Havaux, X., Rochard, C., Huaux, F., & Huygen, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02636.x · Cited by 39
B lymphocytes: Shedding new light on the pathogenesis of systemic sclerosis
Hasegawa, M. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00763.x · Cited by 39
Roberts, M., Luo, X., & Chegini, N. (2005) · Molecular Human Reproduction · doi:10.1093/molehr/gah233 · Cited by 45
Flamini, S., Sergeev, P., de Barros, Z. V., Mello, T., Biagioli, M., Paglialunga, M., Fiorucci, C., Prikazchikova, T. A., Pagano, S., Gagliardi, A., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03704-w · Cited by 42
Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases
Yang, F., Luo, X., Li, J., Yu, L., Zeng, F., Huang, X., Lan, Y., & Liu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113236 · Cited by 44
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics
Serumula, W., Pillay, V., Hadebe, B., & Vorster, M. (2025) · Pharmaceuticals · doi:10.3390/ph18040522 · Cited by 42
Polymorphisms in Inflammasome Genes and Risk of Coal Workers' Pneumoconiosis in a Chinese Population
Ji, X., Hou, Z., Wang, T., Jin, K., Fan, J., Luo, C., Chen, M., Han, R., & Ni, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047949 · Cited by 44
BLT1 Mediates Bleomycin-Induced Lung Fibrosis Independently of Neutrophils and CD4+ T Cells
Lv, J., Xiong, Y., Li, W., Yang, W., Zhao, L., & He, R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600465 · Cited by 40
“However, U75302 treatment had no effect on the production of IL-13 and IL-17A in lung tissue homogenates (Fig.”
BackgroundInfluentialShan, S., Zhang, Y., Wu, M. H., Yi, B., Wang, J., & Li, Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7209 · Cited by 45
Decoding fibrosis: Mechanisms and translational aspects
Schaefer, L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.009 · Cited by 40
Gong, W., Huang, F., Sun, L., Yu, A., Zhang, X., Xu, Y., Shen, Y., & Cao, J. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007000 · Cited by 43
Gonzalez-Polo, V., Molineris, M. P., Cervera, V., Gambaro, S. E., Yantorno, S. E., Descalzi, V., Tiribelli, C., Gondolesi, G. E., & Meier, D. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2018.12.001 · Cited by 42
Immunopathogenesis of Juvenile Systemic Sclerosis
Stevens, A. M., Torok, K. S., Li, S. C., Taber, S. F., Lu, T. T., & Zulian, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01352 · Cited by 49
Exploiting worm and allergy models to understand Th2 cytokine biology
Ramalingam, T. R., Reiman, R. M., & Wynn, T. A. (2005) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000182542.30100.6f · Cited by 37
Self-citationBurton, M. J., Bailey, R. L., Jeffries, D. J., Rajak, S. N., Adegbola, R. A., Sillah, A., Mabey, D. C. W., & Holland, M. J. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4550 · Cited by 38
Metadata
- Authors
- Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-08
- Volume
- 4
- Issue
- 8
- Pages
- 583-594
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2702150
- OpenAlex
- W1983357763
- Cited by
- 1,765
- References
- 135
- Citations by year
- 2026: 46 · 2025: 76 · 2024: 93 · 2023: 104 · 2022: 126 · 2021: 96 · 2020: 99 · 2019: 83 · 2018: 91 · 2017: 95 · 2016: 87 · 2015: 91 · 2014: 94 · 2013: 82 · 2012: 75
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001019, Z01AI000829)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- fibrosis, fibrogenesis, Th1/Th2 paradigm, T helper cells, idiopathic pulmonary fibrosis, liver fibrosis, systemic sclerosis, wound healing, fibroproliferative disorders
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Humans, Macrophages, Transforming Growth Factor beta, Th1 Cells, Th2 Cells, Interleukin-13, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.